Daratumumab is effective in the relapsed or refractory systemic light-chain amyloidosis but associated with high infection burden in a frail real-life population
| Image |  |
|---|---|
| Description | scientific article published on 19 November 2019 |
| Author/s |
author: Helene Demarquette Morgane Nudel Eileen M Boyle Salomon Manier Thierry Facon Zoe Van de Wyngaert |
| Publication date | November 19, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |